Basic Information | Post buying leads | Suppliers |
Name |
3-((3R,4S)-4-Methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
EINECS | N/A |
CAS No. | 1092578-46-5 | Density | 1.296 |
PSA | 88.91000 | LogP | 1.48268 |
Solubility | N/A | Melting Point |
N/A |
Formula | C16H20N6O | Boiling Point | N/A |
Molecular Weight | 312.37 | Flash Point | N/A |
Transport Information | N/A | Appearance | solid or liquid |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4S)-; |
(3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.